We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Builders FirstSource
BLDR
$7.15B
| $6.63M | 0.09% |
523,217
+202,817
| +63% | +$2.88M |
|
227
Constellium
CSTM
$3.76B
| $6.63M | 0.09% |
1,094,492
-173,110
| -14% | -$1.44M |
|
228
Honeywell
HON
$77B
| $6.62M | 0.09% |
77,801
-5,485
| -7% | -$499K |
|
229
AerCap
AER
$23.7B
| $6.58M | 0.09% |
172,000
+72,700
| +73% | +$3.21M |
|
230
PUT
Verizon
VZ
$195B
| $6.53M | 0.09% |
150,000
+148,500
| +9,900% | +$6.85M |
|
231
Fidelity National Information Services
FIS
$23.1B
| $6.51M | 0.09% |
97,086
+85,586
| +744% | +$5.7M |
|
|
RDHL
232
Redhill Biopharma
RDHL
$3.95M
| $6.46M | 0.09% |
+500
| New | +$7.4M |
|
233
Intercontinental Exchange
ICE
$85.6B
| $6.43M | 0.09% |
136,740
-41,155
| -23% | -$1.9M |
|
234
Nucor
NUE
$58.6B
| $6.4M | 0.09% |
+170,502
| New | +$7.31M |
|
|
S
235
PUT
DELISTED
Sprint Corporation
S
| $6.34M | 0.09% |
1,650,000
+1,633,500
| +9,900% | +$6.89M |
|
236
Agnico Eagle Mines
AEM
$73.6B
| $6.33M | 0.09% |
+250,000
| New | +$6.09M |
|
237
Liberty Global Class C
LBTYK
$3.53B
| $6.32M | 0.09% |
177,406
-3,556
| -2% | -$144K |
|
238
Northrop Grumman
NOC
$77.1B
| $6.31M | 0.09% |
38,038
+27,172
| +250% | +$4.55M |
|
239
EQT Corp
EQT
$33.3B
| $6.29M | 0.09% |
178,382
+137,049
| +332% | +$5.59M |
|
240
Carlisle Companies
CSL
$14.3B
| $6.25M | 0.09% |
71,500
-9,201
| -11% | -$920K |
|
241
Ovintiv
OVV
$17.3B
| $6.23M | 0.09% |
193,550
+156,034
| +416% | +$5.98M |
|
|
GRA
242
DELISTED
W.R. Grace & Co.
GRA
| $6.23M | 0.09% |
66,943
-44,310
| -40% | -$4.4M |
|
243
Qorvo
QRVO
$7.99B
| $6.22M | 0.08% |
137,983
-47,367
| -26% | -$2.86M |
|
|
LTRPA
244
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $6.21M | 0.08% |
280,205
-115,806
| -29% | -$3.2M |
|
245
PUT
Citigroup
C
$222B
| $6.2M | 0.08% |
125,000
+123,750
| +9,900% | +$6.76M |
|
246
Globalstar
GSAT
$10.7B
| $6.2M | 0.08% |
263,184
-11,667
| -4% | -$329K |
|
|
SNR
247
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $6.19M | 0.08% |
591,771
+120,212
| +25% | +$1.46M |
|
|
SBNY
248
DELISTED
Signature Bank
SBNY
| $6.16M | 0.08% |
+44,758
| New | +$6.32M |
|
249
American Electric Power
AEP
$69.6B
| $6.14M | 0.08% |
107,987
-224,103
| -67% | -$12.4M |
|
250
PUT
KB Home
KBH
$3.37B
| $6.1M | 0.08% |
450,000
+448,000
| +22,400% | +$6.84M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.